BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31308404)

  • 1. SDHC epi-mutation testing in gastrointestinal stromal tumours and related tumours in clinical practice.
    Casey RT; Ten Hoopen R; Ochoa E; Challis BG; Whitworth J; Smith PS; Martin JE; Clark GR; Rodger F; Maranian M; Allinson K; Madhu B; Roberts T; Campos L; Anstee J; Park SM; Marker A; Watts C; Bulusu VR; Giger OT; Maher ER
    Sci Rep; 2019 Jul; 9(1):10244. PubMed ID: 31308404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent epimutation of SDHC in gastrointestinal stromal tumors.
    Killian JK; Miettinen M; Walker RL; Wang Y; Zhu YJ; Waterfall JJ; Noyes N; Retnakumar P; Yang Z; Smith WI; Killian MS; Lau CC; Pineda M; Walling J; Stevenson H; Smith C; Wang Z; Lasota J; Kim SY; Boikos SA; Helman LJ; Meltzer PS
    Sci Transl Med; 2014 Dec; 6(268):268ra177. PubMed ID: 25540324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SDHC phaeochromocytoma and paraganglioma: A UK-wide case series.
    Williams ST; Chatzikyriakou P; Carroll PV; McGowan BM; Velusamy A; White G; Obholzer R; Akker S; Tufton N; Casey RT; Maher ER; Park SM; Porteous M; Dyer R; Tan T; Wernig F; Brady AF; Kosicka-Slawinska M; Whitelaw BC; Dorkins H; Lalloo F; Brennan P; Carlow J; Martin R; Mitchell AL; Harrison R; Hawkes L; Newell-Price J; Kelsall A; Igbokwe R; Adlard J; Schirwani S; Davidson R; Morrison PJ; Chung TT; Bowles C; Izatt L
    Clin Endocrinol (Oxf); 2022 Apr; 96(4):499-512. PubMed ID: 34558728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.
    Boikos SA; Pappo AS; Killian JK; LaQuaglia MP; Weldon CB; George S; Trent JC; von Mehren M; Wright JA; Schiffman JD; Raygada M; Pacak K; Meltzer PS; Miettinen MM; Stratakis C; Janeway KA; Helman LJ
    JAMA Oncol; 2016 Jul; 2(7):922-8. PubMed ID: 27011036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential
    Giger OT; Ten Hoopen R; Shorthouse D; Abdullahi S; Bulusu VR; Jadhav S; Maher ER; Casey RT
    J Clin Pathol; 2023 Dec; 77(1):34-39. PubMed ID: 36198483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SDHC methylation in gastrointestinal stromal tumors (GIST): a case report.
    Urbini M; Astolfi A; Indio V; Heinrich MC; Corless CL; Nannini M; Ravegnini G; Biasco G; Pantaleo MA
    BMC Med Genet; 2015 Sep; 16():87. PubMed ID: 26415883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and epigenetic alterations of SDH genes in patients with sporadic succinate dehydrogenase-deficient gastrointestinal stromal tumors.
    Shi SS; Wang YF; Bao W; Ye SB; Wu N; Wang X; Xia QY; Li R; Shen Q; Zhou XJ
    Pathol Int; 2019 Jun; 69(6):350-359. PubMed ID: 31273876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
    Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
    Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
    BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Practice Guidance: Surveillance for phaeochromocytoma and paraganglioma in paediatric succinate dehydrogenase gene mutation carriers.
    Wong MY; Andrews KA; Challis BG; Park SM; Acerini CL; Maher ER; Casey RT
    Clin Endocrinol (Oxf); 2019 Apr; 90(4):499-505. PubMed ID: 30589099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Pitfalls of SDH Immunohistochemical Detection in Paragangliomas and Phaeochromocytomas Harbouring Germline
    Santi R; Rapizzi E; Canu L; Ercolino T; Baroni G; Fucci R; Costa G; Mannelli M; Nesi G
    Anticancer Res; 2017 Feb; 37(2):805-812. PubMed ID: 28179334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
    Gill AJ
    Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Schipani A; Nannini M; Astolfi A; Pantaleo MA
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: Beyond phaeochromocytoma and paraganglioma.
    MacFarlane J; Seong KC; Bisambar C; Madhu B; Allinson K; Marker A; Warren A; Park SM; Giger O; Challis BG; Maher ER; Casey RT
    Clin Endocrinol (Oxf); 2020 Nov; 93(5):528-538. PubMed ID: 32686200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Mutation of the Succinate Dehydrogenase C Promoter in a Patient With Two Paragangliomas.
    Richter S; Klink B; Nacke B; de Cubas AA; Mangelis A; Rapizzi E; Meinhardt M; Skondra C; Mannelli M; Robledo M; Menschikowski M; Eisenhofer G
    J Clin Endocrinol Metab; 2016 Feb; 101(2):359-63. PubMed ID: 26652933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Immunohistochemistry and Molecular Analysis of Succinate Dehydrogenase in the Diagnosis of Endocrine and Non-Endocrine Tumors and Related Syndromes.
    Oudijk L; Gaal J; de Krijger RR
    Endocr Pathol; 2019 Mar; 30(1):64-73. PubMed ID: 30421319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
    Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR
    Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation.
    Miettinen M; Killian JK; Wang ZF; Lasota J; Lau C; Jones L; Walker R; Pineda M; Zhu YJ; Kim SY; Helman L; Meltzer P
    Am J Surg Pathol; 2013 Feb; 37(2):234-40. PubMed ID: 23282968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor With SDHC Germline Mutation and Bilateral Renal and Neck Cysts.
    Stanley K; Friehling E; Davis A; Ranganathan S
    Pediatr Dev Pathol; 2019; 22(3):265-268. PubMed ID: 30301441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
    Bayley JP; Weiss MM; Grimbergen A; van Brussel BT; Hes FJ; Jansen JC; Verhoef S; Devilee P; Corssmit EP; Vriends AH
    Endocr Relat Cancer; 2009 Sep; 16(3):929-37. PubMed ID: 19546167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.